产品名称

WAY 362450 - FXR 450 | XL 335

产品货号

Axon 1749 CAS [629664-81-9] MF C25H24F2N2O3MW 438.47 Purity: 99% Soluble in DMSO Description A highly potent, selective, and orally bioavailable farnesoid X receptor (FXR) agonist (EC50: 4 nM, eff=149%); potently induces luciferase reporter expression with an EC50 value of 16 nMpotently induces luciferase reporter expression with an EC50 value of 16 nM References Certificates Categories Extra info B Flutt et al. Discovery of XL335 (WAY-362450), a Highly Potent, Selective, and Orally Active Agonist of the Farnesoid X Receptor (FXR). J. Med. Chem. 2009, 52(4), 904–907. MJ Evans et al. A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296(3), G543-G552. HB Hartman et al. Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR−/− and apoE−/− mice. J. Lipid Res. 2009, 50(6), 1090-1100. S Zhang et al. Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis. J Hepatol. 2009, 51(2), 380-388. Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology FXR NR1H Farnesoid X receptor (FXR) agonist Chemical name Isopropyl 3-(3,4-difluorobenzoyl)-1,1-dimethyl-1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate Parent CAS No. [629664-81-9] Order Size Unit Price Stock 5 mg €135.00 In Stock

产品价格

现货询价，电话：010-67529703

产品规格

产品品牌

axonmedchem

产品概述

产品详情

WAY 362450 - FXR 450 | XL 335

Based on 16 reference(s) in Google Scholar 9 10 16

Axon 1749

CAS [629664-81-9]

MF C25H24F2N2O3
MW 438.47

Purity: 99%
Soluble in DMSO

WAY 362450

Description

A highly potent, selective, and orally bioavailable farnesoid X receptor (FXR) agonist (EC50: 4 nM, eff=149%); potently induces luciferase reporter expression with an EC50 value of 16 nMpotently induces luciferase reporter expression with an EC50 value of 16 nM

B Flutt et al. Discovery of XL335 (WAY-362450), a Highly Potent, Selective, and Orally Active Agonist of the Farnesoid X Receptor (FXR). J. Med. Chem. 2009, 52(4), 904–907.

MJ Evans et al. A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296(3), G543-G552.

HB Hartman et al. Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR−/− and apoE−/− mice. J. Lipid Res. 2009, 50(6), 1090-1100.

S Zhang et al. Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis. J Hepatol. 2009, 51(2), 380-388.

Farnesoid X receptor (FXR) agonist

Chemical name

Isopropyl 3-(3,4-difluorobenzoyl)-1,1-dimethyl-1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate

Parent CAS No.

[629664-81-9]

产品资料